Precision Medicine

被引：14

作者：

Pacanowski, M. ^{[1
]}

Huang, S. M. ^{[1
]}

机构：

[1] US FDA, Off Clin Pharmacol, Silver Spring, MD USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷 / 02期

关键词：

PATIENT;

D O I：

10.1002/cpt.296

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：124 / 129

页数：6

共 15 条

[1]

[Anonymous], 2015, WHIT HOUS FACT SHEET

[2] Direct-to-consumer genetic testing: Perspectives on its value in healthcare [J].

Delaney, S. K. ;

Christman, M. F. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :146-148

[3] Real-world data in the molecular erafinding the reality in the real world [J].

Dickson, D. J. ;

Pfeifer, J. D. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :186-197

[4] Integrated patient and tumor genetic testing for individualized cancer therapy [J].

Hertz, D. L. ;

McLeod, H. L. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :143-146

[5] Therapeutic drug monitoring: A patient management tool for precision medicine [J].

Jang, S. H. ;

Yan, Z. ;

Lazor, J. A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :148-150

[6] Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who? [J].

Johnson, J. A. ;

Weitzel, K. W. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :154-156

[7] Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting [J].

Kalman, L. V. ;

Agundez, J. A. G. ;

Appell, M. Lindqvist ;

Black, J. L. ;

Bell, G. C. ;

Boukouvala, S. ;

Bruckner, C. ;

Bruford, E. ;

Caudle, K. ;

Coulthard, S. A. ;

Daly, A. K. ;

Del Tredici, A. L. ;

den Dunnen, J. T. ;

Drozda, K. ;

Everts, R. E. ;

Flockhart, D. ;

Freimuth, R. R. ;

Gaedigk, A. ;

Hachad, H. ;

Hartshorne, T. ;

Ingelman-Sundberg, M. ;

Klein, T. E. ;

Lauschke, V. M. ;

Maglott, D. R. ;

McLeod, H. L. ;

McMillin, G. A. ;

Meyer, U. A. ;

Mueller, D. J. ;

Nickerson, D. A. ;

Oetting, W. S. ;

Pacanowski, M. ;

Pratt, V. M. ;

Relling, M. V. ;

Roberts, A. ;

Rubinstein, W. S. ;

Sangkuhl, K. ;

Schwab, M. ;

Scott, S. A. ;

Sim, S. C. ;

Thirumaran, R. K. ;

Toji, L. H. ;

Tyndale, R. F. ;

van Schaik, R. H. N. ;

Whirl-Carrillo, M. ;

Yeo, K. T. J. ;

Zanger, U. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :172-185

[8] Industry perspectives on biomarker qualification [J].

Lavezzari, G. ;

Womack, A. W. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :208-213

[9] Providing Access to Genomic Variant Knowledge in a Healthcare Setting: A Vision for the ClinGen Electronic Health Records Workgroup [J].

Overby, C. L. ;

Heale, B. ;

Aronson, S. ;

Cherry, J. M. ;

Dwight, S. ;

Milosavljevic, A. ;

Nelson, T. ;

Niehaus, A. ;

Weaver, M. A. ;

Ramos, E. M. ;

Williams, M. S. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :157-160

[10] Polyallelic structural variants can provide accurate, highly informative genetic markers focused on diagnosis and therapeutic targets: Accuracy vs. Precision [J].

Roses, A. D. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (02) :169-171

← 1 2 →